Can Lantus (insulin glargine) be administered once daily or twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lantus Dosing Frequency

Lantus (insulin glargine) is FDA-approved and typically administered once daily, but can be given twice daily when once-daily dosing fails to provide adequate 24-hour coverage, particularly in patients with type 1 diabetes or those with high glycemic variability. 1

Standard Once-Daily Dosing

  • The American Diabetes Association recommends Lantus be administered once daily at the same time each day as the standard approach for both type 1 and type 2 diabetes. 1
  • The once-daily dosing provides relatively constant basal insulin levels over 24 hours without pronounced peaks, which is the primary pharmacokinetic advantage of insulin glargine. 2, 3
  • Lantus can be given at any time of day (morning, evening, or any convenient time), though consistency in timing from day to day is important. 4

When Twice-Daily Dosing Is Appropriate

The American Diabetes Association explicitly recognizes that insulin glargine may require twice-daily dosing when once-daily administration fails to provide 24-hour coverage. 1 Specific clinical situations warranting twice-daily administration include:

  • Inadequate 24-hour basal coverage - when glucose patterns show the insulin effect wearing off before the next dose 1
  • Persistent nocturnal hypoglycemia with morning hyperglycemia - suggesting the single dose peaks too early then wanes 1
  • Type 1 diabetes with high glycemic variability - where more stable basal coverage is needed 1
  • Labile type 1 diabetes - where twice-daily dosing is often most effective 4
  • Obese, insulin-resistant patients requiring high volumes - where splitting the dose may improve absorption and reduce injection site discomfort 4

Critical Dosing Thresholds

  • When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, adding prandial insulin becomes more appropriate than continuing to escalate basal insulin alone or splitting to twice-daily. 1, 5
  • The decision to split Lantus is based on inadequate 24-hour coverage or specific glycemic patterns, not on reaching a particular dose number. 1
  • Clinical signals suggesting the need for twice-daily dosing include bedtime-to-morning glucose differential ≥50 mg/dL, indicating uneven basal coverage throughout the day. 1

Practical Considerations

  • Twice-daily Lantus requires more injections than the standard once-daily regimen, which may affect patient adherence. 4
  • When splitting to twice-daily, the total daily dose is typically divided into two equal or near-equal doses given approximately 12 hours apart. 1
  • Before splitting to twice-daily dosing, ensure that prandial insulin needs have been adequately addressed, as postprandial hyperglycemia should not be treated by increasing or splitting basal insulin. 1

Common Pitfall to Avoid

  • Do not split Lantus to twice-daily dosing simply because the total daily dose seems "high" - instead, evaluate whether the patient needs prandial insulin coverage rather than more basal insulin. 1 Signs of "overbasalization" (basal dose >0.5 units/kg/day, hypoglycemia, high glucose variability) indicate the need for prandial insulin, not twice-daily basal dosing. 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Guideline

Maximum Daily Dose of Lantus (Insulin Glargine)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dose of Lantus (insulin glargine) for a patient with a current regimen of 20 units, undergoing an Esophagogastroduodenoscopy (EGD) and colonoscopy, who takes their usual dose the evening prior to the procedure?
Can I use Lantus (insulin glargine) twice daily (BID) or once daily (QD)?
Is it better to administer 54 units of Lantus (insulin glargine) once daily or twice daily?
What adjustments should be made to the treatment plan for a patient with uncontrolled hyperglycemia on Lantus (insulin glargine) 12 units?
What is the recommended increase in Lantus (insulin glargine) dose for a patient with hyperglycemia, who previously used an insulin pump with basal needs ranging from 19-29 units, and is now taking 10 units of Lantus with a fasting blood glucose level of 220 and overnight blood glucose level of 179?
After how many days can we shift from single antiplatelet therapy (APT) to dual antiplatelet therapy (DAPT) for a patient with a large stroke due to large artery disease?
Can electroconvulsive therapy (ECT) cause permanent brain damage and permanent memory loss in patients with a history of psychiatric illness?
What are the possible causes of a waddling gait in individuals of all ages?
What is the recommended treatment approach for a patient with a history of psychiatric illness using ultra brief pulse Electroconvulsive Therapy (ECT)?
What are the different types of nasal speculums used in patients of various ages and medical conditions?
What does it mean for an adult with a history of gallbladder disease, who has undergone a cholecystectomy, to have mild secondary intrahepatic and extrahepatic biliary duct ectasia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.